Zeina Azrak

Note: on 100% secondment from July 2023-Jan 2024 as Senior Manager, Vepdegestrant Access Strategy

• Develop & perform local market access plans and list/net pricing strategies across Gulf markets throughout the product life cycle at pre-launch, launch and post-launch.
• Develop local value propositions and equip customer-facing colleagues with key value messages to support enlisting & reimbursement of new launches.
• Meet and engage public and private payers across key accounts in Gulf to understand payer needs', present value proposition (clinical & economic) and facilitate enlisting and reimbursement.
• Cross-functional collaboration with local cross-functional team (V&E, regulatory/commercial/finance/medical), regional PHI, and global PHI colleagues to provide recommendations on pricing and access environment.
• Member of Kuwait & UAE pricing working group in Pharmaceutical Research and Manufacturers Association Gulf (PhRMAG) to meet & provide recommendations for industry policy shaping.

• Handled the global pricing & access strategy of a pipeline breast cancer product (Vepdegestrant).
• Support the development of payer value proposition and payer insights.
• Co-Develop the US and Global Pricing Market Access strategy.
• Develop Negotiation Milestone Calendar & tracker.
• Align on opportunities and challenges with the cross-functional teams to achieve objectives.

• Develop and present comprehensive portfolio optimization assessment of HBU portfolio through cross-functional collaboration with regulatory, commercial, medical and supply colleagues to provide recommendation and identify optimization strategies to local, regional and global commercial teams.
• Develop deep-dive assessment for Yemen market to develop and recommend long-term strategic outlook.

• Developed and managed annual list price assumptions exercise in collaboration with local, regional, and global PHI teams.
• Ensured aligned understanding of pricing environment across Gulf organization to establish strong pricing mindset.
• Maximized business revenue and profits through executing optimal pricing strategies and mitigation plans through cross-functional collaborations with local stakeholders (H&V, Finance, Commercial and Regulatory), regional PHI and global PHI teams.
• Developed and implemented pricing analytics platform that was recognized and awarded in two global platforms.
• Collaborated with global pricing teams to determine and execute pricing strategies and generate recommendations on potential IRP risks and opportunities.

• In-depth understanding of 8 regulatory authorities- pricing guidelines and dynamics across Gulf
• Developed tools to ensure smooth price certification process and accurate pricing database.
• Contributed to information synthesis in annual list price assumptions exercise.